Literature DB >> 14688518

A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience.

Michelangelo Fiorentino1, Antonia D'Errico, Barbara Corti, Silvia Casanova, Lorenza Ridolfi, Nicola Venturoli, Elena Sestigiani, Walter F Grigioni.   

Abstract

BACKGROUND: We describe the Emilia-Romagna screening protocol for all multiorgan donors within this region of Italy and report on the first 2 years of implementation.
SETTING: Setting is a 24-hour multidisciplinary call service covering the 16 intensive care units in Emilia-Romagna (3,969,000 inhabitants) and a centralised pathology center, directed by a transplant coordination center. STUDY POPULATION AND PERIOD: All 271 effective donor candidates presenting in Emilia-Romagna in 2001-2002. PROTOCOL: Anamnesis, external examination, and thorough laboratory and instrumental screening is followed by sampling of internal effusions and evaluation of all internal organs. All suspect findings are then investigated by extemporary pathologic evaluation. To fit national legal requirements, candidates are classified as standard risk (no transmissible risk); nonstandard risk (low-risk of transmission, eligibility restricted to certified clinical emergencies pending informed consent); and unacceptable risk (unconditional exclusion because of high-risk pathologies).
RESULTS: The protocol was successfully implemented for all 271 candidates. In addition to 14 independent exclusions, clinical suspicion of cancer was raised for 61 donors presenting with 82 lesions or effusions. Along with one case of lymph-node tuberculosis (unacceptable risk), histocytologic screening revealed eight cases of malignancy (5 prostate, 1 papillary-thyroid, 1 follicular-thyroid, and 1 renal cell, all nonstandard risk); the remainder were benign (standard risk). Protocol implementation led to exclusion of 8 (3.0%) candidates (1 nonstandard risk transplantation was performed).
CONCLUSIONS: This stringent protocol-now adopted with some modifications at a national level-provides an initial example of a feasible intervention aimed at maximising donation safety while rationalizing use of marginal donors.

Entities:  

Mesh:

Year:  2003        PMID: 14688518     DOI: 10.1097/01.TP.0000092306.29395.96

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network.

Authors:  Albino Eccher; Letizia Lombardini; Ilaria Girolami; Francesca Puoti; Gianluigi Zaza; Giovanni Gambaro; Amedeo Carraro; Giovanni Valotto; Luca Cima; Luca Novelli; Desley Neil; Umberto Montin; Aldo Scarpa; Matteo Brunelli; Alessandro Nanni Costa; Antonia D'Errico
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

Review 2.  Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature.

Authors:  Brian Kim; Tinsay Woreta; Po-Hung Chen; Berkeley Limketkai; Andrew Singer; Nabil Dagher; Andrew Cameron; Ming-Tseh Lin; Ihab Kamel; Ahmet Gurakar
Journal:  Dig Dis Sci       Date:  2012-12-16       Impact factor: 3.199

3.  Practice and Attitudes of Donor Coordinator Roles Regarding Physical Examination of Potential Organ and Tissue Donors in Australia.

Authors:  Justine A C Holloway; Kristen Ranse; Kasia Bail; Maggie Jamieson; Frank Van Haren
Journal:  Transplant Direct       Date:  2019-07-23

4.  Can deceased donor with recurrent primary brain tumor donate kidneys for transplantation?

Authors:  Suresh Kumar; Pranjal R Modi; Bipin C Pal; Jayesh Modi
Journal:  Indian J Urol       Date:  2016 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.